VIRIOS THERAPEUTICS, INC. Common Stock ($0.0001 par value per share)Capital on Demand Sales Agreement • July 14th, 2023 • Virios Therapeutics, Inc. • Pharmaceutical preparations • New York
Virios Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), as follows:
